Lumida
/KVUE
⌘K
Kenvue Inc

Kenvue Inc

KVUE
$18.98USD-0.21%-0.04 today

MARKET CAP

36.4B

P/E (TTM)

16.4x

FWD P/E

15.1x

DAY RANGE

$19 – $19

52W RANGE

$14
$23

AI Summary

Stalk
Buy NowMedium

KVUE remains in a Stage 2 advancing regime under a strong Lockout Rally continuation, with medium-term bullish polarity despite a multi-year downtrend. The recent pullback into rising EMAs provides a tactical buy entry, supported by the active Lockout Rally override that justifies immediate participation even in overbought context. Primary risks include a deeper retracement below the EMAs and a failure to sustain above the 50-day SMA, which would invalidate the bullish bias.

  • Tylenol brand share resilient: 12 quarters growth, 61.6% gross margin.
  • Marketing spend up ~20% to drive brand equity and sales.
  • Organic sales down 4.2% in Q2; full-year growth below guidance.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRIC
TREND